We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVM icon
3776
CEL-SCI Corp
CVM
$23.9M
$56K ﹤0.01%
801
+362
+82% +$31.8K
ERNA icon
3777
Eterna Therapeutics
ERNA
$4.97M
$56K ﹤0.01%
47
-148
-76% -$209K
IOBT
3778
DELISTED
IO Biotech
IOBT
$56K ﹤0.01%
24,200
+5,777
+31% +$15.3K
DWTX
3779
Dogwood Therapeutics
DWTX
$61.2M
$56K ﹤0.01%
9,416
+2,352
+33% +$17.7K
NURO
3780
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$55K ﹤0.01%
4,607
+1,082
+31% +$15.4K
ADIL
3781
Adial Pharmaceuticals
ADIL
$8.36M
$54K ﹤0.01%
403
+172
+74% +$30.1K
MBOT icon
3782
Microbot Medical
MBOT
$120M
$54K ﹤0.01%
17,995
-1,100
-6% -$4.56K
NBSE
3783
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$54K ﹤0.01%
14,261
-108
-0.8% -$554
AKAN icon
3784
Akanda
AKAN
$3M
$53K ﹤0.01%
+6
New +$78.8K
AMBO
3785
Ambow Education Holding
AMBO
$5.66M
$53K ﹤0.01%
17,314
-620
-3% -$1.91K
DMAC icon
3786
DiaMedica Therapeutics
DMAC
$350M
$53K ﹤0.01%
+33,619
New +$45.3K
ASXC
3787
DELISTED
Asensus Surgical, Inc.
ASXC
$53K ﹤0.01%
152,473
+56,300
+59% +$22.9K
RHE
3788
DELISTED
Regional Health Properties, Inc.
RHE
$53K ﹤0.01%
16,100
-245
-1% -$649
FURY
3789
Fury Gold Mines
FURY
$105M
$52K ﹤0.01%
122,724
+61,500
+100% +$23K
OST icon
3790
Ostin Technology Group
OST
$52K ﹤0.01%
220
+68
+45% +$18K
PRSO icon
3791
Peraso
PRSO
$10.8M
$52K ﹤0.01%
1,785
-295
-14% -$15.6K
PRDS
3792
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$51K ﹤0.01%
+29,886
New +$37.9K
HUMA icon
3793
Humacyte
HUMA
$193M
$50K ﹤0.01%
23,800
-184,200
-89% -$559K
JFIN
3794
Jiayin Group
JFIN
$122M
$50K ﹤0.01%
21,896
+7,196
+49% +$16.2K
YGMZ
3795
DELISTED
MingZhu Logistics Holdings
YGMZ
$50K ﹤0.01%
461
+113
+32% +$32.4K
VORB
3796
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$50K ﹤0.01%
+26,800
New +$71.7K
THER
3797
DELISTED
THERATECHNOLOGIES INC COM
THER
$50K ﹤0.01%
+56,400
New +$50K
HSDT icon
3798
Solana Company
HSDT
$96.3M
$49K ﹤0.01%
4
-4
-50% -$40.8K
RDHL
3799
Redhill Biopharma
RDHL
$4.14M
$49K ﹤0.01%
+349
New +$151K
TC
3800
TuanChe
TC
$51M
$49K ﹤0.01%
197
+31
+19% +$39.1K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.